Registration link below for Wednesday March 18, 2026 at 4 PM EDT Phio invites individual and institutional investors, as well ...
A wanted criminal and his accomplice were arrested by the Navi Mumbai Police for allegedly selling narcotic substances under the guise of running a goat farm ...
Tech, Grand Valley Local Schools and Conneaut Area City Schools gathered at the Kent State University Ashtabula campus ...
Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...
Sanjay Upadhyay, BJP MLA from Borivali, told the Maharashtra Assembly that acres of mangroves have been destroyed ...
Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.
Barclays 28th Annual Global Healthcare Conference March 11, 2026 9:30 AM EDTCompany ParticipantsSara Pellegrino ...
The U.S. Food and Drug Administration (FDA) declined approval of retifanlimab-dlwr for patients with metastatic non-small cell lung cancer (NSCLC) in the United States because of manufacturing ...
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at ...
Zacks Investment Research on MSN
INCY wins EC approval for label expansion of oncology drug Zynyz
Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz (retifanlimab) for a second indication. The drug is now approved in the EU in ...
In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results